Opioid Safety

The Dangers of Opioids: Q&A with Bradley T. Truax, MD

Anesthesiology News recently published an article about new research that found that increased used of HYDROmorphone (e.g. Dilaudid) over morphine triggers more opioid-related adverse events and higher readmission rates. In light of the study, the Physician-Patient Alliance for Health & Safety (PPAHS) interviewed patient safety expert Bradley T. Truax, MD, who has written extensively about the dangers of Dilaudid.

By Sean Power

PPAHS: The study found that HYDROmorphone use has increased for pain treatment in hospital inpatients by 22% and 17% among surgical and medical patients, respectively, while morphine usage has decreased by 22% and 6%. It found higher rates of naloxone rescue for patients on HYDROmorphone and also found that the 30-day readmission rate was 1.37% higher in surgical patients and 3.41% higher in medical patients receiving HYDROmorphone. Should patients and physicians be alarmed by these numbers?

Read More